Biotechnology and India
Upcoming SlideShare
Loading in...5
×
 

Biotechnology and India

on

  • 314 views

Market insight report on Biotechnology in India covers products, technologies and services used in the Indian Biotechnology Industry. The report studies the Bio Pharma, Herbal Drugs, Bioservices and ...

Market insight report on Biotechnology in India covers products, technologies and services used in the Indian Biotechnology Industry. The report studies the Bio Pharma, Herbal Drugs, Bioservices and Bioindustrial markets in detail. Market estimations and predictions are illustrated by sector and by technology. Major Pharmaceutical, Bio Fuels, Bioinformatics companies and Contract Research Organizations serving the industry are also covered in the report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. An Indian perspective is presented along 44 exclusive graphically represented exhibits. Business profiles of 100 major companies are discussed in the report. The report serves as a guide to Indian Biotechnology industry, as it covers more than 300 companies that are engaged in biotechnology R&D, discovery, testing and supply of products and services.

Statistics

Views

Total Views
314
Views on SlideShare
314
Embed Views
0

Actions

Likes
0
Downloads
7
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Biotechnology and India Biotechnology and India Document Transcript

  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 1 BIOTECHNOLOGY IN INDIA MARKET SIZE Scope of the Study This report gives an insight into the different sectors of biotechnology in India and their impact on the growth of industry. The study provides Indian biotechnology market analysis for Bio-Agriculture, Bio- Industry and Other (Bio Pharma, Bio Services, and Bio Informatics). Bio-Agriculture includes Bio Pesticides, Bio Fertilizers and Other (GM crops). Bio Industry includes Fermentation Products, Bio Fuels and Bio Polymers. The study includes estimates and projections for the total Indian Biotechnology market. Business profiles of 99 major companies are discussed in the report. The report serves as a guide to Indian Biotechnology industry, as it covers more than 266 companies that are engaged in biotechnology R&D, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving biotechnology industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. This report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets Analytics and data presented in this report pertain to several parameters such as –  Indian Market Sizes, Market Shares, Market Trends  Product (Indian) Market Sizes, Market Shares, Market Trends  Technology Trends  Corporate Intelligence  Key Companies By Sales, Brands, Products  Consumer Behavioral Patterns
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 2  Other Strategic Business Affecting Data
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 3 Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines – Indian market analysis, product segmentation, Indian market analysis by product segment, market trends, M&A, R&D, competitive landscape, technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. This report is uniquely researched and the methodology includes  Need and Scope of Study  Product Definitions  Segmental Analysis  Regional Analysis  Exclusive Data Analytics  Corporate Intelligence  Feedback Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies.
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 4 II. REPORT SYNOPSIS Biotechnology - A Brief Introduction Biotechnology is considered as a most promising technology which is very complex in nature and capable of taking mankind to new heights. In the next few decades it is expected to facilitate large-scale technological advancements. This advancement is expected to be of greater prominence and pervasive than the developments achieved by the IT field. The related developments of other fields such as life sciences are improving the opportunities of biotechnology. The combination of genomics, proteomics, biology and bioinformatics is considered as a driving force for the development of biotechnology. Some of the important areas which require to be focused for the comprehensive development of the biotech field are generation of excellent opportunities, proper wealth creation practices, expansion of commercial prospects and enhancing of industrial developments. Biotechnology in India In India, the requirement for maintaining a separate department for the development and intensification of biology and biotechnology research was felt in the early 1980s. The government established a special institutional agenda for the development of biology and biotechnology in the country. Some of the governmental research organizations such as University Grants Commission (UGC), Council of Scientific & Industrial Research (CSIR),Indian Council of Agricultural Research (ICAR), Indian Council of Medical Research (ICMR), Department of Science & Technology offer great support in the development of modern biology and biotechnology in India. The early major biotech organizations in India were Biocon, Panacea Biotech, Bharath Biotech, Bangalore Genei (which exploited recombinant DNA technology but not for human use) and the Serum Institute of India. Lot of research work carried out by the government organizations at that time was very useful for private and budding biotech companies. CCMB (Centre for cellular and molecular biology) located in Hyderabad played a major role in developing the hepatitis B vaccine for Shantha Biotech. Delhi based Centre for Biochemical Technology (CBT), a lab for developing and making different types of biochemicals, was established in 1997. This later became Frontier Biology Laboratory by reorienting its research activities. The research at the Indian Institute of Science (IISc) and National Centre for Biological Sciences (NCBS) in Bangalore maintains international standards in research. Post genome sequencing, and the enthusiastic interests of venture capitalists, the biotech scene in India too has become very vibrant. Biocon was the first biotech company started in India (1978). The later period was wait and watch until 1997. Avestha Gengraine was set up in the year 1998, Strand Genomics in the year 2000 and Metahelix and Gangagen in the year 2001. Once Pharma companies started investing in biotech companies, there has been a boom in the field of biotechnology. India has strong biotechnological assets and human resources.  Highly qualified, efficient, and experienced pool of scientists and engineers; and exceptional R & D and cost effective manufacturing makes India a favorite market for the development of biotechnological fields.
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 5  Small and big national research laboratories employ thousands of scientists.  Approximately 300 college level educational centers and training establishments offer diplomas, degrees, and Masters degrees in bio-informatics, biotechnology, genetics and related biological sciences.  These colleges and educational institutions are responsible for churning out approximately a lakh biotechnological aspirants each year.  About 100 medical colleges cater to 16, 000 medical practitioners each year.  The vast knowledge pool of India further produces approximately 25,000 postgraduates in the field of biotechnology.  The number of people acquiring doctorates in biosciences and engineering is around 1500 each year. The field of biotechnology has the potential to convert the vast biological resources present in the country into economic wealth and employment opportunities. The development of innovative products and availability of exceptional services can impact the renewable resources and bring about greater effectiveness in industrial practices. It can also restrict environmental degradation and provide more bio- based economy to the country. The main problem with the Indian agricultural sector is the uncertainty of the rains and the requirement to produce more farm products to meet the requirements of the people from diminishing per capita arable land. The field of Biotechnology has the potential to accept this challenge and ensure the livelihood security of millions of agricultural families by following technological farming techniques. The efforts put in by the field in the last few decades have won applause from both the public and private sectors. These agencies have come forward to promote life sciences and biotechnology. The support rendered by these organizations has led to significant progress in the areas of R&D, HRD and development of infrastructure. The commencement of product patent formulation in early 2005 has enabled development of quality products and services in the field. Research & Development Activities in the Field of Biotechnology In India, the R&D in the field of science and technology is being promoted and undertaken with the government’s intervention and sponsorships. There are various governmental research wings responsible for the enduring research in this field. Some of the government organizations playing a major role in biotechnology development in India:  Indian Council for Medical Research (ICMR)  Centre for cellular and Molecular Biology (CCMB)  Department of Biotechnology (DBT)  Department of Science and Technology (DST)  Department of Atomic Energy (DAE)  University Grants Commission (UGC)  Indian Council for Agricultural Research (ICAR)  Council for Scientific and Industrial Research (CSIR) UGC: Responsible for release of grants, determination, coordination and maintenance of standards Department of Biotechnology: The Department of Biotechnology (DBT) is promoting the development of specialised degrees, such as MSc in Biotechnology or Bio-informatics in several institutions. The State
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 6 Governments are responsible for the establishment of State Universities and colleges, and provide plan grants for their development and non-plan grants for their maintenance. The introduction of the patent regime has encouraged a number of private institutions in the research front. Council for Scientific and Industrial Research (CSIR): CSIR is a vast research organization in the governmental sector with approximately 40 laboratories and 81 field stations, numerous extension centers and regional centers spread across the country. The prime role is to carry out R&D in the various disciplines of biotechnology and life sciences. The organization consists of approximately 22,000 highly qualified professionals capable of carrying out multidisciplinary research activities. Indian Council for Agricultural Research (ICAR): ICAR is involved in the research activities to promote science and technology programs in the agricultural sector. Like CSIR, it also has a number of institutes, national research centers, and project directorates. Apart form these, it is also involved in collaboration with the State Agricultural Universities (SAUs) all over the country to study and understand the agricultural related problems of the individual states. This organization has an overall manpower of about 29,000 people, of which nearly 6,500 are involved in active research programs. The SAUs present in each state collectively have manpower of approximately 25,000 scientists who are actively involved in research, training and extension education. Further 5,500 scientists are involved in the various other projects looked after by ICAR. Segmentation of Biotechnology Industry in India Exhibit 1. Segmentation of Biotechnology Industry in India Sector Biopharma Bioservices Bioindustrial Other (Bioagro & Bioinformatics) Biopharma Vaccines Therapeutics Diagnostics Other BioIndustrial Fermentation Products Bio Fuels Bio Polymers © RIT Figures, 2013
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 7 III. MARKET DYNAMICS Market Overview Biotechnology has great promise in India. Demand and availability of bio fertilizers is expected to increase as they are inexpensive, and are formed from renewable energy resources i.e. cultivable life forms compared to chemical fertilizers that are known to harm the environment and exhaust non-renewable energy sources. Biofertilizer production does not result in any toxic substances released into environment. Hence they are safe for both crops and the farmer, whereas production of chemical fertilizers causes environmental pollution. Unlike chemical fertilizers which lose their nutrient value with one crop, Biofertilizers are more long lasting as they improve the yields of subsequent crops as well, reducing the cost of agricultural produce. India’s energy needs will be met in the future through the use of biofuels reducing the dependence on the imported oil. By use of biofuels there is a reduction in emission of harmful pollutants i.e. reduction in green house emissions, thus leading to the growth of the Biofuel industry. Bio polymers though now account for a small share in the market, are expected to show an upward swing in their growth as they are found to have applications in many areas such as, food industry, medicine and material Science. India’s energy needs will be met through the use of biofuels in the near future. Indian Market Analysis Indian Biotechnology market is projected to reach about US$ XX.XX billion by 2020 from a market of US$ XX.XX billion in 2015, and is estimated to reach XX.XX billion by 2012 growing at a compounded annual growth rate (CAGR) of XX.XX % during the analysis period 2005-2020.
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 8 Exhibit 2. Biotechnology - Indian Value Market Estimations & Predictions (2005-2020) in US$ Million Year Value 2005 XX.XX 2006 XX.XX 2007 XX.XX 2008 XX.XX 2009 XX.XX 2010 XX.XX 2011 XX.XX 2012 XX.XX 2013 XX.XX 2014 XX.XX 2015 XX.XX 2016 XX.XX 2017 XX.XX 2018 XX.XX 2019 XX.XX 2020 XX.XX CAGR % XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 9 Exhibit 3. Biotechnology in India - Market Estimations & Predictions (2005 - 2020) for Biopharma, Bioservices, Bioindustrial and Other in US$ Million Year/Sector Biopharma Bioservices Bioindustrial Other (includes Bioagro and Bioinformatics) Total 2005 XX.XX XX.XX XX.XX XX.XX XX.XX 2006 XX.XX XX.XX XX.XX XX.XX XX.XX 2007 XX.XX XX.XX XX.XX XX.XX XX.XX 2008 XX.XX XX.XX XX.XX XX.XX XX.XX 2009 XX.XX XX.XX XX.XX XX.XX XX.XX 2010 XX.XX XX.XX XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX XX.XX XX.XX © RIT Figures , 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million Biopharma Bioservices Bioindustrial Other (includes Bioagro & Bioinformatics)
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 10 IV. PRODUCT/ TECHNOLOGY RESEARCH Major Biotech Events in India Year Company Location Activity 1978 Biocon (India’s first Biotech Company ) Bangalore Industrial Enzymes 1981 CCMB Hyderabad DNA & r-DNA Based Research 1984 Institute of Microbial Technology Chandigarh R&D Activities in Microbial Technology 1986 DBT (Department of Biotechnology) Govt of India To Promote biology and biotechnology at academic and industry levels . 1987 National Institute of Immunology New Delhi Immunology Research 1989 Bangalore Genei Pvt Ltd. Produces Enzymes and related reagents for genetic Engineering . 1991 National Center for Biological Sciences Bangalore Molecular Biology R&D 1993 Shantha Biotechnics Hyderabad Development of Proteins, Vaccines, Therapeutic Antibodies. (India’s First recombinant product Hepatitis B) 1996 Bharat Biotech Hyderabad Manufacture of Vaccines and Biotherapeutics 1998 Monsanto Rsearch Bangalore Approval from DBT to Mahyco-Monsanto for conducting Bt – Cotton trials. Establishes an R&D research center at IISC Plant Genomics 1999 Avesthagen Bangalore A plant genomics company set up by NCBS scientists Bio Pharmaceuticals , Bio Agriculture 2000 Wockhardt Mumbai Biovac –B Hepatitis B Vaccine it`s First recombinant biotech product 2001 Reliance life Sciences Stem Cell based research and product development 2001 Wockhardt Mumbai Wepox- Recombinant Erythropoietin is used for the treatment of anemia and chronic renal failure. 2003 Wockhardt Mumbai Wosulin -Launched the Recombinant Human Insulin 2004 Biocon Bangalore Launch of Human Insulin Insugen (first company to have successfully commercialized the large-scale manufacture of human insulin, using a proprietary methylotrophic yeast based technology.) 2006 IICT Hyderabad Best patent award from IDMA for development of anti- cancer agents . More…. © RIT, 2013
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 11 Exhibit 4. List of Major States Growing Bt Cotton: 2006 Area Under Cultivation in Hectares S. No States Cultivated Area 1 Maharashtra 1, 840 2 Andhra Pradesh 830 3 Gujarat 470 4 Madhya Pradesh 310 6 Karnataka 85 7 Tamil Nadu 45 8 Other 210 Total 3, 800 (Source: ISAAA, 2006) About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Research – As Good as the Methodology is!  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities Maharashtra Andhra Pradesh Gujarat Madhya Pradesh Karnataka Tamil Nadu Other Cultivated Area
  • RITMIR018: Biotechnology in India – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 12  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets © COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company. DISCLAIMER RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.